Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. (Q36204031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Norman E Cameron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

T Michael Gibson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

Annals of the New York Academy of Sciences

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

1043

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

784-792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16037306%20AND%20SRC:MED&resulttype=core&format=json

Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

The effects of hypoxia on the excitability of the isolated peripheral nerves of alloxan-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Glycogen accumulation in the nerves and kidney of chronically diabetic rats. A quantitative electron microscopic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Diabetes causes an early reduction in autonomic ganglion blood flow in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Mechanisms of diabetic vasculopathy: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

The role of advanced glycation in the pathogenesis of diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Regulation of aldose reductase and the polyol pathway activity by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091

Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1333.091